XML 39 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Reporting
 3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Segment Reporting SEGMENT REPORTING Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (“CODM”), or decision-making group, in deciding how to allocate resources and in assessing performance. Our CODM is our Chief Executive Officer. Our reportable segments include diagnostic and information technology-based products and services for the veterinary market, which we refer to as the Companion Animal Group (“CAG”), water quality products (“Water”) and diagnostic products and services for livestock and poultry health and to ensure the quality and safety of milk and improve dairy efficiency, which we refer to as Livestock, Poultry and Dairy (“LPD”). Although our LPD segment does not meet the quantitative thresholds to be reported as a separate segment, we believe it is important to disaggregate these revenues as a major product and service category within our Other reportable segment given its distinct markets, and therefore we have elected to report LPD as a reportable segment. Our Other operating segment combines and presents products and services for the human medical diagnostics (“OPTI Medical”) market with our out-licensing arrangements. Assets are not allocated to segments for internal reporting purposes.
The following is a summary of segment performance:
(in thousands)For the Three Months Ended March 31,
CAGWaterLPDOtherConsolidated Total
2021     
Revenue$692,767 $34,040 $39,270 $11,630 $777,707 
Income from operations$213,210 $14,772 $13,808 $5,832 $247,622 
Interest expense, net(7,532)
Income before provision for income taxes240,090 
Provision for income taxes35,801 
Net income204,289 
Less: Net income attributable to noncontrolling interest32 
Net income attributable to IDEXX Laboratories, Inc. stockholders$204,257 
2020
Revenue$551,996 $34,149 $34,154 $6,037 $626,336 
Income from operations$118,659 $15,882 $9,663 $121 $144,325 
Interest expense, net(7,552)
Income before provision for income taxes136,773 
Provision for income taxes24,917 
Net income111,856 
Less: Net income attributable to noncontrolling interest29 
Net income attributable to IDEXX Laboratories, Inc. stockholders$111,827 
See “Note 3. Revenue Recognition” for a summary of disaggregated revenue by reportable segment and by major product and service category for the three months ended March 31, 2021 and 2020.